hypoglycemia

An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of dangerously low glucose levels, or hypos, in animals. The drug holds great promise for the tens of millions of diabetics worldwide.

Nanosized particles that release glucagon, the hormone responsible for raising blood glucose levels, on-demand could mean that diabetics don’t need to worry about potentially dangerous low blood sugar levels, according to new research.